A PHP Error was encountered

Severity: Warning

Message: fopen(/var/lib/php/sessions/ci_sessionb84t0jfbe8uf4kuahgla14a3gqnr4c9r): Failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 177

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)

Filename: Session/Session.php

Line Number: 137

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once

Laser vaccine adjuvants: Light-augmented immune responses. | LitMetric

Laser vaccine adjuvants: Light-augmented immune responses.

Vaccine

Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan. Electronic address:

Published: November 2021

Adjuvants are essential for ensuring the efficacy of modern vaccines. Considering frequent local and systemic adverse reactions, research into the development of safer and more effective adjuvants is being actively conducted. In recent years, the novel concept of laser vaccine adjuvants, which use the physical energy of light, has been developed. For long, light has been known to affect the physiological functions in living organisms. Since the development of lasers as stable light sources, laser adjuvants have evolved explosively in multiple ways over recent decades. Future laser adjuvants would have the potential not only to enhance the efficacy of conventional vaccine preparations but also to salvage candidate vaccines abandoned during development because of insufficient immunogenicity or owing to their inability to be combined with conventional adjuvants. Furthermore, the safety and efficacy of non-invasive laser adjuvants make them advantageous for vaccine dose sparing, which would be favorable for the timely and equitable global distribution of vaccines. In this review, we first describe the basics of light-tissue interactions, and then summarize the classification of lasers, the history of laser adjuvants, and the mechanisms by which different lasers elicit an immune response.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2021.09.042DOI Listing

Publication Analysis

Top Keywords

laser adjuvants
16
adjuvants
9
laser vaccine
8
vaccine adjuvants
8
laser
6
adjuvants light-augmented
4
light-augmented immune
4
immune responses
4
responses adjuvants
4
adjuvants essential
4

Similar Publications

Therapeutic effects of a femtosecond laser on rheumatoid arthritis in rats: Attenuation of oxidative stress and inflammation.

J Photochem Photobiol B

March 2025

Genetics and Molecular Biology Division, Zoology Department, Faculty of Science, Beni-Suef University, 62521 Beni-Suef, Egypt.

Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disorder characterized by joint damage and persistent pain. Despite advances in treatment, there is currently no definitive cure for RA, and the side effects of available medications often limit their long-term use. Therefore, this study investigated the therapeutic potential of femtosecond laser irradiation (FSL) in treating arthritis induced by complete Freund's adjuvant (CFA) in a rat model.

View Article and Find Full Text PDF

Background: Chlorhexidine digluconate (CHG) is considered the most effective and safe antimicrobial agent in dentistry. Recently, it has often been produced in the form of preparations with additional substances that may modify its effect.

Objectives: The aim of the present study was to compare the efficacy of various simple and combined CHG rinses against selected bacterial and yeast strains.

View Article and Find Full Text PDF

Biomimetic Self-Oxygenated Immunoliposome for Cancer-Targeted Photodynamic Immunotherapy.

Int J Nanomedicine

March 2025

Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China.

Objective: Photodynamic therapy (PDT) is a promising strategy with significant clinical application potential for tumor treatment. However, the tumor hypoxia and limited efficacy against tumor metastasis present significant limitations in the clinical application of PDT. To alleviate tumor hypoxia for PDT against tumor growth and metastasis, we developed a self-oxygenated immunoliposome by encapsulating the catalase (CAT) within the liposome cavity and loading the photosensitizer chlorin e6 (Ce6) and immunoadjuvant MPLA in the lipid bilayer of the immunoliposome (CAT@LP-Ce6-A).

View Article and Find Full Text PDF

Thermal Protection Techniques for Image-guided Musculoskeletal Ablation.

Radiographics

April 2025

From the Department of Radiology, Division of Musculoskeletal Imaging and Intervention, University of Washington, 4245 Roosevelt Way NE, Box 354755, Seattle, WA 98105 (P.C.T., A.A., A.P., E.A., N.H., M.C.); Department of Radiology, Division of Musculoskeletal Imaging and Intervention, University of Colorado Anschutz Medical Campus, Aurora, Colo (C.K.H.); and Department of Radiology, Penn State Health, Hershey, Pa (L.M.S.).

Percutaneous image-guided thermal ablation has gained wide acceptance among physicians for the treatment of benign and malignant tumors of the musculoskeletal system. Increasing evidence to support the efficacy of thermal ablation techniques in primary and adjuvant treatment of soft-tissue sarcomas, treatment of oligometastatic disease to bone and soft tissue, and metastatic pain palliation has positioned interventional oncology alongside surgery, systemic therapies, and radiation therapy as the fourth pillar of modern comprehensive cancer care. Despite the expanding indications and increasing use in clinical practice, thermal ablation carries a significant risk of injury to the adjacent vulnerable structures, predominantly the skin, bowel, and neural structures.

View Article and Find Full Text PDF

This case report describes the use of photobiomodulation (PBM) as a complementary therapy in a 45-year-old patient with mammary tuberculosis (TB). The patient received conventional treatment, including antibiotic therapy and analgesics. Three months after the diagnosis, breast pain persisted (Visual Analog Scale [VAS] score: 8), and the mammary lesions had not healed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!